Evicenter
MarkdownMedical informationP&T meetings
AD109 (aroxybutynin-atomoxetine)

Obstructive sleep apnea

Also known as Oxnimbi
Manufacturer
Apnimed
Launch
Not announced
Last updated
183 sources

Section 6 of 6

References

183 sources

  1. Acquavella et al. (2020) (opens in a new tab)
  2. Aetna Zepbound prior authorization policy (2026) (opens in a new tab)
  3. Aishah et al. (2021) (opens in a new tab)
  4. Aishah et al. (2023) (opens in a new tab)
  5. Ali et al. (2025) (opens in a new tab)
  6. American Academy of Sleep Medicine Zepbound provider fact sheet (2026) (opens in a new tab)
  7. Annemans et al. (2026) (opens in a new tab)
  8. Apnimed CHEST 2025 release (2025) (opens in a new tab)
  9. Apnimed debt financing release (2026) (opens in a new tab)
  10. Apnimed Form 10-Q, third quarter (2026) (opens in a new tab)
  11. Apnimed LunAIRo protocol (2025) (opens in a new tab)
  12. Apnimed LunAIRo statistical analysis plan (2025) (opens in a new tab)
  13. Apnimed LunAIRo topline release (2025) (opens in a new tab)
  14. Apnimed NDA acceptance release (2026) (opens in a new tab)
  15. Apnimed presentation (2026) (opens in a new tab)
  16. Apnimed prospectus (2026) (opens in a new tab)
  17. Apnimed SASS monetization release (2026) (opens in a new tab)
  18. Apnimed SynAIRgy protocol (2025) (opens in a new tab)
  19. Apnimed SynAIRgy publication release (2026) (opens in a new tab)
  20. Apnimed SynAIRgy statistical analysis plan (2025) (opens in a new tab)
  21. Apnimed SynAIRgy topline release (2025) (opens in a new tab)
  22. Apnimed third quarter results release (2026) (opens in a new tab)
  23. Axsome Sunosi prescribing information (2023) (opens in a new tab)
  24. Ayas et al. (2006) (opens in a new tab)
  25. Azarbarzin et al. (2019) (opens in a new tab)
  26. Azarbarzin et al. (2026) (opens in a new tab)
  27. Bailey et al. (2022) (opens in a new tab)
  28. Baillieul et al. (2026) (opens in a new tab)
  29. Bailly et al. (2024) (opens in a new tab)
  30. Baldwin et al. (2001) (opens in a new tab)
  31. Barbé et al. (2012) (opens in a new tab)
  32. Benjafield et al. (2019) (opens in a new tab)
  33. Berry et al. (2012) (opens in a new tab)
  34. Bierer (2022) (opens in a new tab)
  35. Boers et al. (2025) (opens in a new tab)
  36. Borsoi et al. (2022) (opens in a new tab)
  37. Cadby et al. (2015) (opens in a new tab)
  38. Chervin et al. (1999) (opens in a new tab)
  39. Cistulli et al. (2019) (opens in a new tab)
  40. ClinicalTrials.gov NCT04580394 (opens in a new tab)
  41. ClinicalTrials.gov NCT04580394 results (opens in a new tab)
  42. ClinicalTrials.gov NCT04631107 (opens in a new tab)
  43. ClinicalTrials.gov NCT04631107 results (opens in a new tab)
  44. ClinicalTrials.gov NCT05071612 (opens in a new tab)
  45. ClinicalTrials.gov NCT05071612 results (opens in a new tab)
  46. ClinicalTrials.gov NCT05811247 (opens in a new tab)
  47. ClinicalTrials.gov NCT05811247 API record (opens in a new tab)
  48. ClinicalTrials.gov NCT05811247 results (opens in a new tab)
  49. ClinicalTrials.gov NCT05813275 (opens in a new tab)
  50. ClinicalTrials.gov NCT05813275 API record (opens in a new tab)
  51. ClinicalTrials.gov NCT05813275 results (opens in a new tab)
  52. ClinicalTrials.gov NCT05813275 version 22 (opens in a new tab)
  53. ClinicalTrials.gov NCT06400615 (opens in a new tab)
  54. ClinicalTrials.gov NCT06566820 (opens in a new tab)
  55. CMS Medicare GLP-1 Bridge FAQs (2026) (opens in a new tab)
  56. CMS National Coverage Determination 240.4 (2008) (opens in a new tab)
  57. CMS National Coverage Determination 240.4.1 (2009) (opens in a new tab)
  58. CMS Quality Payment Program measure 277 (2026) (opens in a new tab)
  59. CMS Quality Payment Program measure 279 (2026) (opens in a new tab)
  60. Cole et al. (2026) (opens in a new tab)
  61. Eckert (2018) (opens in a new tab)
  62. Eckert et al. (2013) (opens in a new tab)
  63. Eli Lilly Zepbound prescribing information (2026) (opens in a new tab)
  64. Epstein et al. (2009) (opens in a new tab)
  65. Esmaeili et al. (2025) (opens in a new tab)
  66. Frost & Sullivan (2016) (opens in a new tab)
  67. Gell et al. (2026a) (opens in a new tab)
  68. Gell et al. (2026b) (opens in a new tab)
  69. Gottlieb et al. (1999) (opens in a new tab)
  70. Gottlieb et al. (2010) (opens in a new tab)
  71. Grace et al. (2013) (opens in a new tab)
  72. Hedner et al. (2022) (opens in a new tab)
  73. Heinzer et al. (2015) (opens in a new tab)
  74. Hoog et al. (2025) (opens in a new tab)
  75. Horner et al. (2026) (opens in a new tab)
  76. Hudgel et al. (2018) (opens in a new tab)
  77. Hurst et al. (2026) (opens in a new tab)
  78. ICER obesity final report (2025) (opens in a new tab)
  79. Incannex Form 10-K (2026) (opens in a new tab)
  80. Janssen DITROPAN XL prescribing information (2021) (opens in a new tab)
  81. Johns (1991) (opens in a new tab)
  82. Kapur et al. (1999) (opens in a new tab)
  83. Kapur et al. (2017) (opens in a new tab)
  84. Kaufmann et al. (2026) (opens in a new tab)
  85. Kendzerska et al. (2014) (opens in a new tab)
  86. Kent et al. (2021) (opens in a new tab)
  87. Kim (2026) (opens in a new tab)
  88. Kim et al. (2015) (opens in a new tab)
  89. Kinouchi et al. (2023) (opens in a new tab)
  90. Kuna et al. (2011) (opens in a new tab)
  91. Leng et al. (2017) (opens in a new tab)
  92. Lilly STRATTERA prescribing information (2026) (opens in a new tab)
  93. Lloyd et al. (2022) (opens in a new tab)
  94. Luyster et al. (2017) (opens in a new tab)
  95. Malhotra et al. (2021) (opens in a new tab)
  96. Malhotra et al. (2024) (opens in a new tab)
  97. Marin et al. (2005) (opens in a new tab)
  98. Marshall et al. (2008) (opens in a new tab)
  99. Mazzotti et al. (2019) (opens in a new tab)
  100. McEvoy et al. (2016) (opens in a new tab)
  101. McSharry et al. (2014) (opens in a new tab)
  102. Mehra and Mokhlesi (2026) (opens in a new tab)
  103. Mehra et al. (2006) (opens in a new tab)
  104. Messineo et al. (2023) (opens in a new tab)
  105. National Sleep Foundation (2025) (opens in a new tab)
  106. Newman et al. (2005) (opens in a new tab)
  107. Nieto et al. (2000) (opens in a new tab)
  108. Nyxoah Form 20-F (2026) (opens in a new tab)
  109. Ojile et al. (2026) (opens in a new tab)
  110. Osman et al. (2026) (opens in a new tab)
  111. Parish and Lyng (2003) (opens in a new tab)
  112. Patel et al. (2024) (opens in a new tab)
  113. Patel et al. (2025a) (opens in a new tab)
  114. Patel et al. (2025b) (opens in a new tab)
  115. Patel et al. (2026a) (opens in a new tab)
  116. Patel et al. (2026b) (opens in a new tab)
  117. Patil et al. (2019) (opens in a new tab)
  118. Peker et al. (2016) (opens in a new tab)
  119. Pépin et al. (2021) (opens in a new tab)
  120. Peppard et al. (2000a) (opens in a new tab)
  121. Peppard et al. (2000b) (opens in a new tab)
  122. Peppard et al. (2013) (opens in a new tab)
  123. Pietzsch et al. (2011) (opens in a new tab)
  124. Pietzsch et al. (2015) (opens in a new tab)
  125. Prado et al. (2026) (opens in a new tab)
  126. Punjabi et al. (2009) (opens in a new tab)
  127. Qaseem et al. (2013) (opens in a new tab)
  128. Ramar et al. (2015) (opens in a new tab)
  129. Randerath et al. (2021) (opens in a new tab)
  130. Randerath et al. (2025) (opens in a new tab)
  131. Redline et al. (2003) (opens in a new tab)
  132. Redline et al. (2010) (opens in a new tab)
  133. Rehman et al. (2026) (opens in a new tab)
  134. Reichmuth et al. (2005) (opens in a new tab)
  135. Rogers et al. (2016) (opens in a new tab)
  136. Rosen et al. (2012) (opens in a new tab)
  137. Rosenberg et al. (2022) (opens in a new tab)
  138. Rotenberg et al. (2016) (opens in a new tab)
  139. Ruehland et al. (2009) (opens in a new tab)
  140. Sajith Kumar et al. (2025) (opens in a new tab)
  141. Sánchez-de-la-Torre et al. (2020) (opens in a new tab)
  142. Sánchez-de-la-Torre et al. (2023) (opens in a new tab)
  143. Sands et al. (2018) (opens in a new tab)
  144. Schweitzer et al. (2023a) (opens in a new tab)
  145. Schweitzer et al. (2023b) (opens in a new tab)
  146. Senaratna et al. (2017) (opens in a new tab)
  147. Sert Kuniyoshi et al. (2026) (opens in a new tab)
  148. Sönmez et al. (2025) (opens in a new tab)
  149. Srijithesh et al. (2019) (opens in a new tab)
  150. Stepnowsky et al. (2019) (opens in a new tab)
  151. Stewart et al. (2025) (opens in a new tab)
  152. Streatfeild et al. (2019) (opens in a new tab)
  153. Strollo et al. (2014) (opens in a new tab)
  154. Strollo et al. (2024) (opens in a new tab)
  155. Strollo et al. (2025a) (opens in a new tab)
  156. Strollo et al. (2025b) (opens in a new tab)
  157. Strollo et al. (2025c) (opens in a new tab)
  158. Strollo et al. (2026a) (opens in a new tab)
  159. Strollo et al. (2026b) (opens in a new tab)
  160. Strollo et al. (2026c) (opens in a new tab)
  161. Taranto-Montemurro et al. (2019) (opens in a new tab)
  162. Taranto-Montemurro et al. (2020) (opens in a new tab)
  163. Taranto-Montemurro et al. (2023) (opens in a new tab)
  164. Taranto-Montemurro et al. (2025) (opens in a new tab)
  165. Teva Nuvigil prescribing information (2017) (opens in a new tab)
  166. Tishler et al. (2003) (opens in a new tab)
  167. Tregear et al. (2009) (opens in a new tab)
  168. Tregear et al. (2010) (opens in a new tab)
  169. VA/DoD insomnia and obstructive sleep apnea guideline (2025) (opens in a new tab)
  170. Wang et al. (2013) (opens in a new tab)
  171. Weaver and Grunstein (2008) (opens in a new tab)
  172. Wellman et al. (2011) (opens in a new tab)
  173. Wickwire et al. (2020) (opens in a new tab)
  174. Wickwire et al. (2022) (opens in a new tab)
  175. Woodson et al. (2018) (opens in a new tab)
  176. Yaffe et al. (2011) (opens in a new tab)
  177. Yao et al. (2026) (opens in a new tab)
  178. Yeghiazarians et al. (2021) (opens in a new tab)
  179. Young et al. (1993) (opens in a new tab)
  180. Young et al. (1997) (opens in a new tab)
  181. Young et al. (2008) (opens in a new tab)
  182. Yu et al. (2017) (opens in a new tab)
  183. Zhao et al. (2026) (opens in a new tab)